ErbB3/HER3 does not homodimerize upon neuregulin binding at the cell surface

被引:126
作者
Berger, MB
Mendrola, JM
Lemmon, MA [1 ]
机构
[1] Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Grad Grp Biochem & Mol Biophys, Philadelphia, PA 19104 USA
来源
FEBS LETTERS | 2004年 / 569卷 / 1-3期
关键词
heterodimer; epidermal growth factor; receptor; tyrosine kinase; signalling;
D O I
10.1016/j.febslet.2004.06.014
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
To understand signaling by the neuregulin (NRG) receptor ErbB3/HER3, it is important to know whether ErbB3 forms homodimers upon ligand binding. Previous biophysical studies suggest that the ErbB3 extracellular region remains monomeric when bound to NRG. We used a chimeric receptor approach to address this question in living cells, fusing the extracellular region of ErbB3 to the kinase-active intracellular domain of ErbB1. The ErbB3/ErbB1 chimera responded to NRG only if ErbB2 was co-expressed in the same cells, whereas an ErbB4/ErbB1 chimera responded without ErbB2. We, therefore, suggest that ErbB3 is an obligate heterodimerization partner because of its inability to homodimerize. (C) 2004 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:332 / 336
页数:5
相关论文
共 36 条
  • [21] Heregulin reverses the oligomerization of HER3
    Landgraf, R
    Eisenberg, D
    [J]. BIOCHEMISTRY, 2000, 39 (29) : 8503 - 8511
  • [22] Lewis GD, 1996, CANCER RES, V56, P1457
  • [23] LONARDO F, 1990, New Biologist, V2, P992
  • [24] The ErbB signaling network: receptor heterodimerization in development and cancer
    Olayioye, MA
    Neve, RM
    Lane, HA
    Hynes, NE
    [J]. EMBO JOURNAL, 2000, 19 (13) : 3159 - 3167
  • [25] The oncogenic ErbB-2/ErbB-3 heterodimer is a surrogate receptor of the epidermal growth factor and betacellulin
    Pinkas-Kramarski, R
    Lenferink, AEG
    Bacus, SS
    Lyass, L
    van de Poll, MLM
    Klapper, LN
    Tzahar, E
    Sela, M
    van Zoelen, EJJ
    Yarden, Y
    [J]. ONCOGENE, 1998, 16 (10) : 1249 - 1258
  • [26] Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions
    PinkasKramarski, R
    Soussan, L
    Waterman, H
    Levkowitz, G
    Alroy, I
    Klapper, L
    Lavi, S
    Seger, R
    Ratzkin, BJ
    Sela, M
    Yarden, Y
    [J]. EMBO JOURNAL, 1996, 15 (10) : 2452 - 2467
  • [27] Neu differentiation factor neuregulin isoforms activate distinct receptor combinations
    PinkasKramarski, R
    Shelly, M
    Glathe, S
    Ratzkin, BJ
    Yarden, Y
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (32) : 19029 - 19032
  • [28] MOLECULAR-CLONING AND EXPRESSION OF AN ADDITIONAL EPIDERMAL GROWTH-FACTOR RECEPTOR-RELATED GENE
    PLOWMAN, GD
    WHITNEY, GS
    NEUBAUER, MG
    GREEN, JM
    MCDONALD, VL
    TODARO, GJ
    SHOYAB, M
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (13) : 4905 - 4909
  • [29] Riese DJ, 1996, ONCOGENE, V12, P345
  • [30] The epidermal growth factor receptor couples transforming growth factor-alpha, heparin-binding epidermal growth factor-like factor, and amphiregulin to Neu, ErbB-3, and ErbB-4
    Riese, DJ
    Kim, ED
    Elenius, K
    Buckley, S
    Klagsbrun, M
    Plowman, GD
    Stern, DF
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (33) : 20047 - 20052